GRAIL, Inc.

US$121.44As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GRALHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR 140.33%
Div yield —
ROE (17.31%)
Diagnostics & Research
Beta (5Y) 2.87
PE TTM —
TSR TTM 32.10%
Mkt cap US$5.460B
ROIC (14.29%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$120
(0.86%)
397.15%
Hold 3|6|6|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.75
1.77
1.98
2.09
21.08%
20.91%
21.92%
15.81%
Revenue$M
346.0
341.7
347.2
365.5
(0.74%)
(6.26%)
(2.28%)
4.81%
Peers (US$5.460B)
Cap (US$)
PE
5.981B
—
5.376B
124.2x
4.573B
26.69x
Capital
TTM
5Y
10Y
Leveragex
1.223
0.363
0.326
EBIT/Intx
0.290
0.594
0.389
Own earn%
169.18
(2.19)
(20.44)
Sh yield%
18.11
31.55
30.70
Owners
Insiders/Inst%
13.86
29.03
Short interest%
2.44
SBC / revenue%
1.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–6
$1 testx
0.7
Incr. ROIC%
8